Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet; 24 of the 69 sources its claims cite were checked for support.

Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS)

Open access

Abstract

Purpose of Review: The polycystic ovary syndrome (PCOS) is an endocrine dysfunction associated with a myriad of metabolic disorders and high rate of infertility. In order to aid its management, several lifestyle/dietary interventions have been evaluated. Very low-calorie ketogenic diet (VLCKD) is rapidly showing promising benefits not only in obesity but also in the treatment of other metabolic diseases. The main objective of this review is to assess the scientific evidence in support of this dietary pattern as an effective measure for treating PCOS and the metabolic disorders associated with it. Recent Findings: Preliminary data suggested significant improvements in body weight and composition, metabolic profile (glucose, serum insulin, triglycerides, total and low-density lipoprotein cholesterol), and insulin resistance following VLCKD. However, the evidence is still scarce and needs to be more substantiated. Summary: Weight reduction in women with PCOS has been shown to improve metabolic derangements and body composition, but there is no consensus on the ideal dietary pattern or macronutrient composition. There is some evidence supporting the possible role of the Mediterranean diet in improving infertility (along with other well-known metabolic benefits) in women with PCOS. Of note, VLCKD might be considered a potential intervention for the short-term treatment of PCOS, but it must be prescribed and carefully guided by professionals.

Overview

CoChat Summary

TL;DR

This narrative review assesses evidence for ketogenic diets, especially very low-calorie ketogenic diet (VLCKD), as a medical prescription in women with PCOS. It concludes that VLCKD may be effective for short-term treatment of PCOS and associated metabolic disorders, but evidence remains scarce and the diet must be professionally prescribed and supervised.

Key findings

  • Preliminary data suggest VLCKD improves body weight and composition, metabolic profile (glucose, serum insulin, triglycerides, total and LDL cholesterol), and insulin resistance in PCOS, but the evidence is still scarce and needs to be more substantiated.
  • In the Paoli et al. trial of 14 overweight women with PCOS on a 12-week KEMEPHY protocol, average weight loss was 9.43 kg (81.19 ± 8.44 kg to 71.76 ± 6.66 kg; p < 0.001), BMI decreased by 3.35 (28.84 ± 2.10 to 25.49 ± 1.69 kg/m²; p < 0.001), and glucose, insulin, HOMA-IR, triglycerides, total cholesterol, and LDL cholesterol significantly decreased.
  • A retrospective study of 25 women with obesity and PCOS undergoing VLCKD for 12 weeks showed significant decreases in anti-Müllerian hormone and significant increases in progesterone and SHBG, suggesting possible benefit for ovarian reserve and luteal function.
  • Other dietary patterns have evidence in PCOS: a meta-analysis of 19 clinical trials (1193 patients) found restricted diets significantly improved insulin resistance, fasting glucose, and body composition; a meta-analysis of 8 studies (412 women with PCOS and overweight/obesity) found low-glycemic-index diets improved clinical and biochemical features.

Methods

  • Narrative review; the authors state the main objective is to assess scientific evidence supporting VLCKD as an effective measure for treating PCOS and its associated metabolic disorders.
  • The paper synthesizes prior literature, including clinical trials, meta-analyses, and reviews, with cited PCOS-specific studies such as 14 overweight women on KEMEPHY for 12 weeks, 25 women with obesity and PCOS on VLCKD for 12 weeks, and 9 women with PCOS and obesity on a high-protein very low-calorie diet for 4 weeks.
  • No systematic search strategy, inclusion criteria, or formal meta-analysis is reported in the text.

Limitations

  • The authors state that evidence is still scarce and needs to be more substantiated; there is no consensus on the ideal dietary pattern or macronutrient composition for PCOS.
  • The authors state that long-term VLCKD interventions for PCOS have not been published, and VLCKD has contraindications and side effects, so it should be limited to specific patients and prescribed under professional supervision.
  • Evident from the text: this is a narrative review without a reported systematic search or formal quality assessment, and many cited PCOS-specific ketogenic studies are small and short-term (e.g., 14 women for 12 weeks; 25 women for 12 weeks; 9 women for 4 weeks), limiting generalizability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s13668-023-00456-1

Cites

Statistics

Nothing to recompute.

Figures

Fig. 1 Metabolic and reproductive effects of VLCKD on PCOS. VLCKD very low-calorie ketogenic diet, PCOS polycystic ovary syndrome. ⊥ indicates a decrease, while ↑ indicates an increase
Fig. 1 Metabolic and reproductive effects of VLCKD on PCOS. VLCKD very low-calorie ketogenic diet, PCOS polycystic ovary syndrome. ⊥ indicates a decrease, while ↑ indicates an increaseCC BY · PubMed Central

Verification

Claims the paper makes

21 Valid · 1 Not valid · 37 Not checked · 6 Own results and interpretations

17 more claims · 8 with their cited sources checked

Create a free account to see all 65 claims and to verify the 45 references still open.

See all claims — free account
  • It may state two separate claims as one. 37
  • Probably not a substantial claim. 8

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

The citation lists are queued

They are fetched later and appear here then.

References 48 · Cited by 62

Metadata

Authors
Barrea, L., Verde, L., Camajani, E., Cernea, S., Frias-Toral, E., Lamabadusuriya, D., Ceriani, F., Savastano, S., Colao, A., & Muscogiuri, G.
Affiliations
  • Pegaso University (IT)
  • University of Naples Federico II (IT)
  • Sapienza University of Rome (IT)
  • Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO)
  • General Sir John Kotelawala Defence University (LK)
  • Universidad de la República de Uruguay (UY)
  • Federico II University Hospital (IT)
Corresponding author
Muscogiuri, Giovanna
Venue
Current Nutrition Reports
Published
2023-01-25
Volume
12
Issue
1
Pages
56-64
ISSN
2161-3311 (ISSN-L)
OpenAlex
W4318025967
Cited by
62
References
48
Citations by year
2026: 17 · 2025: 18 · 2024: 16 · 2023: 11
FWCI
2.49
Type
journal article
Language
en
Open access
Licence
Locations
  • Current Nutrition Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Greater South Information System
Funders
Università degli Studi di Napoli Federico II
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
  • Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
Keywords
polycystic ovary syndrome, ketogenic diet, very low-calorie ketogenic diet, insulin resistance, weight loss, body composition, metabolic disorders, infertility, Mediterranean diet, macronutrient composition
MeSH terms
Female, Humans, Infertility, Metabolic Diseases, Polycystic Ovary Syndrome, Diet, Mediterranean, Diet, Ketogenic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS). https://app.cochat.ai/papers/10.1007/s13668-023-00456-1
The paper
Barrea, L., Verde, L., Camajani, E., Cernea, S., Frias-Toral, E., Lamabadusuriya, D., Ceriani, F., Savastano, S., Colao, A., & Muscogiuri, G. (2023). Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS). Current Nutrition Reports. https://doi.org/10.1007/s13668-023-00456-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.